Skip to content

Candlr

All Your Cannabis & Psychedelic News in One Place

Tag: Lexaria Biosciences News

January 12, 2021

Lexaria Bioscience Corp. Announces Uplisting to Nasdaq Capital Market and Pricing of $9.6 Million Upsized Public Offering

Continue reading →

December 7, 2020

Lexaria to Highlight its DehydraTECH(TM) Technology at Four Upcoming Investor Conferences

Continue reading →

November 19, 2020

Lexaria Bioscience Sells Non-Pharmaceutical THC-Related Assets for CDN$3.85M

Continue reading →

November 5, 2020November 5, 2020

Lexaria Bioscience Advances 2021 Strategic Initiatives

Continue reading →

October 22, 2020

Lexaria Proprietary DehydraTECH-Enabled CBD Powders Business Growing Faster than ExpectedGrowth now expected to exceed 500% from fiscal Q4 2020 to fiscal Q1 2021

Continue reading →

October 21, 2020October 21, 2020

Lexaria Bioscience Granted First European Patent for DehydraTECH Technology

Continue reading →

Menu

Home
About Candlr
- Legal Disclaimer
- Services
Blog
News
Featured Companies
Psychedelic Sector
Cannabis Sector
Contact

Get Early Access

Enter your email address to get early access to Candlr app.

Join 4,118 other followers

Email Address:

About Candlr

Candlr is an Investment & Marketing firm developing the best in class stock screener app for traders and investors.

For early access to Candlr app please subscribe HERE.

Hours & Info

1161 W Georgia St, Vancouver, BC V6E 0C6

Info@cannabis-investment-group.com

Follow Blog via Email

Enter your email address to follow this blog and receive notifications of new posts by email.

Join 4,118 other followers

Email Address: